First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 1(3): e104-11, 2014 Dec.
Article
em En
| MEDLINE
| ID: mdl-27029228
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article